But_home
But_blogshome
But_forum
Icon_rss_infobarSubscribe to receive updates
on new articles and posts from this blog.
 
Pixel

Episode #17: Diabetes and cardiovascular disease with Darren McGuire

Please note that the audio will stop and restart at the beginning of the file when submitting a comment. Veuillez notez que le fichier audio s’arrête et recommence au début lorsqu’un commentaire est publié.
DOWNLOAD
Download this episode in your preferred format:

itunes
mp3
Diabetics account for up to 25% of the patients seen in the chronic ambulatory setting and for as much as 40% of patients enrolled in clinical trials of patients with ischemic heart disease. To shine light on these disturbing statistics and chart a path forward for the care of diabetic patients with cardiovascular disease Dr Darren McGuire joins the show for an informative discussion that focuses on:

  • Diabetes: The problem in general and background on a growing epidemic
  • Medical treatment of diabetics, FDA guidelines for the development of drugs to treat diabetes, and cardiovascular safety issues
  • Specificity of diabetes in cardiovascular disease: What's different about diabetics undergoing revascularization?

What are your thoughts? Join in by commenting below.

CommentsCommentaires

Add your own commentsFaire un commentaire





 



About The Bob Harrington Show
Take part in this new interactive series! Start by joining Dr Harrington and his guests for a frank and insightful review of the latest clinical trials, events and education in the realm of cardiology. Then it’s your turn: share your thoughts by writing them in the comments box (at left) or by phoning our studios and leaving a voice message: 1-866-996-5440. There’s a show posted every two weeks, why not join in? We value the diverse opinions of our readership — that includes you — and look forward to a hearty exchange!
About Dr Robert A Harrington
Dr Robert A Harrington is a Professor of Medicine at Duke University, Director of the Duke Clinical Research Institute, and a practicing interventional cardiologist. He is the recipient of an NIH Roadmap contract to investigate “best practices” among clinical trial networks, and is a Fellow of the ACC, AHA, SCAI, and American College of Chest Physicians. In addition, he currently serves as a member of the FDA Cardiovascular and Renal Drugs Advisory Committee and is a member of the NHLBI’s study section for clinical trials. A member of the ACC’s Board of Trustees, Dr Harrington chaired the ACC 2006 Annual Scientific Sessions.